SMYRNE BALAN-LOUIS: Open Payments
NPI 1841886546 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,867 in 166 payments from 43 companies in 2025. Trend: 2023 $1,765 · 2024 $3,542 · 2025 $3,867
Food & beverage: $3,684Education: $183
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $339 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $319 |
| AstraZeneca Pharmaceuticals LP | 12 | $256 |
| Celgene Corporation | 14 | $249 |
| Novartis Pharmaceuticals Corporation | 19 | $231 |
| Daiichi Sankyo Inc. | 8 | $210 |
| PFIZER INC. | 15 | $199 |
| Alexion Pharmaceuticals, Inc. | 4 | $185 |
| Merck Sharp & Dohme LLC | 7 | $150 |
| Karyopharm Therapeutics Inc. | 1 | $124 |
Products named: Nubeqa, RYBREVANT, REBLOZYL, ENHERTU, ULTOMIRIS, KISQALI, KEYTRUDA, XPOVIO.
Industry payments across FL — which companies pay providers there.
